MARKET

NVO

NVO

Novo-Nordisk A/S
NYSE
42.74
-0.72
-1.65%
Opening 12:23 09/15 EDT
OPEN
42.73
PREV CLOSE
43.45
HIGH
42.93
LOW
42.46
VOLUME
3.63M
TURNOVER
--
52 WEEK HIGH
61.21
52 WEEK LOW
34.20
MARKET CAP
189.05B
P/E (TTM)
10.68
1D
5D
1M
3M
1Y
5Y
1D
Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool · 11h ago
Novo Nordisk Stock (NVO) Is Falling Despite Rebrand to ‘Novo’ — Here’s Why
TipRanks · 12h ago
Novo Nordisk Nears DKK 9.3 Billion in Share Buybacks Under 2026 Programme
TipRanks · 14h ago
Novo Nordisk rebranding as ‘Novo,’ announces cultural reset
TipRanks · 14h ago
Novo Nordisk (0QIU) Gets a Sell from Deutsche Bank
TipRanks · 16h ago
Ascendis Pharma to regain rights to TransCon technology-based products
TipRanks · 1d ago
Eli Lilly has more than 30% of new patients on oral weight-loss meds: exec
Seeking Alpha · 1d ago
Novo Nordisk Is Dropping Some Weight. Can a Rebrand Save the Stock?
Barron‘s · 1d ago
More
About NVO
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Webull offers Novo Nordisk A/S (ADR) stock information, including NYSE: NVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVO stock methods without spending real money on the virtual paper trading platform.